Rosnilimab Emerges as a Potential Advance in Rheumatoid Arthritis as Physicians Look to the Next Wave of Pipeline Innovation

Summary

Rosnilimab is positioned as a potential advance in rheumatoid arthritis treatment as part of physician-focused pipeline innovation efforts. The article provides limited specific details about clinical data or development stage.